Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Kereiakes, DJ; Lincoff, AM; Anderson, KM; Achenbach, R; Patel, K; Barnathan, E; Califf, RM; Topol, EJ; EPIC Investigators, ; EPILOG investigators, ; EPISTENT investigators,

Published Date

  • September 15, 2002

Published In

Volume / Issue

  • 90 / 6

Start / End Page

  • 628 - 630

PubMed ID

  • 12231090

Pubmed Central ID

  • 12231090

International Standard Serial Number (ISSN)

  • 0002-9149

Digital Object Identifier (DOI)

  • 10.1016/s0002-9149(02)02568-7

Language

  • eng

Conference Location

  • United States